Zugui Zhang, Ph.D.
Dr. Zhang is the director of biostatistics at the Value Institute and affiliated professor in the Program of Medical Engineering in the Department of Mechanical Engineering at the College of Engineering at the University of Delaware. He obtained his PhD in biostatistics from the University of Iowa and Masters in statistics from Arizona State University. He has a broad background in health outcomes research, health economics, public health, epidemiology, and biostatistics, with specific training and expertise in key research areas for this application. As the director of biostatistics at the Christiana Care Health System, he carries out study design, methodological research, data analysis, propose research grants, writing drafts as the lead author for peer reviewed research papers, and teaching medicine fellows courses in biostatistics and research method. His current research focuses on statistical methods for survival analysis, predictive modeling, health economics, modelling risk scores and applications in medicine generally.
He has published and presented articles and abstracts at the American Heart Association, the American Public Health Association, and Joint Statistical Meeting, among others. He was invited to give presentations in AHA scientific meeting and statistical meetings. In recent years, he has published manuscripts in New England Journal of Medicine, The American Journal of Medicine, Journal of the American College of Cardiology, Circulation, Circulation-Cardiovascular Quality and Outcomes, Radiology, Pediatrics, Journal of Clinical Hypertension, and The Canadian Journal of Cardiology, among others.
He has worked extensively on several large, international, multi-center, randomized clinical trials and observational studies, including COURAGE (the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation), EXTRACT (the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment), ASCERT (American College of Cardiology Foundation-The Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies), and SPRINT(Systolic Blood Pressure Intervention Trial).